Loading clinical trials...
Loading clinical trials...
Philips HeartStart Intrepid 12-lead Electrocardiogram (ECG) Study - The ICE (Intrepid Clinical Engineering) Study
The purpose of this research study is to collect clinical data to validate a software update for 12-lead electrocardiogram monitoring.
The purpose of this study is to validate the Philips DXL electrocardiogram Algorithm works as intended in the HeartStart Intrepid Monitor/Defibrillator after a software update was completed to address instances of high impedance. This study will also determine the diagnostic quality of the 12-lead electrocardiogram tracing from the HeartStart Intrepid Monitor/Defibrillator.
Age
0 - 89 years
Sex
ALL
Healthy Volunteers
Yes
Lehigh Pulmonary Associates, PA (D/B/A Florida Lung & Sleep Associates)
Lehigh Acres, Florida, United States
Start Date
October 3, 2022
Primary Completion Date
November 2, 2022
Completion Date
November 2, 2022
Last Updated
March 25, 2024
60
ACTUAL participants
12 lead Electrocardiogram
DIAGNOSTIC_TEST
Lead Sponsor
Philips Clinical & Medical Affairs Global
NCT04493970
NCT04189822
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06948266